Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.
Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium.
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
Design and implementation of the multi-arm, multi-stage Therapeutics for Inpatients with COVID-19 (TICO) platform master protocol: An Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative.
The Aging Imageomics Study: rationale, design and baseline characteristics of the study population.
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy.
A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.